Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jaya Kala, Rebecca Nelson, Christopher Drudge, Allen Zhou, Suzanne Ward & Megan Bourque. (2023) Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis. ClinicoEconomics and Outcomes Research 15, pages 165-179.
Read now
Read now
Alexander Wang, Frank Cirrone, Francis Andrew De Los Reyes, John Papadopoulos, Shella Saint Fleur-Lominy & Elaine Xiang. (2022) High-dose methotrexate dosing strategy in primary central nervous system lymphoma. Leukemia & Lymphoma 63:6, pages 1348-1355.
Read now
Read now
Xiao Li, Zhongguo Sui, Fanbo Jing, Wen Xu, Xiangpeng Li, Qie Guo, Shuhong Sun & Xiaolin Bi. (2019) Identifying risk factors for high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia. Cancer Management and Research 11, pages 6265-6274.
Read now
Read now
Richard A. Larson. (2018) Managing CNS disease in adults with acute lymphoblastic leukemia. Leukemia & Lymphoma 59:1, pages 3-13.
Read now
Read now
Priya Tiwari, M.K. Thomas, Subha Pathania, Deepa Dhawan, Y.K. Gupta, Sreenivas Vishnubhatla & Sameer Bakhshi. (2015) Serum Creatinine Versus Plasma Methotrexate Levels to Predict Toxicities in Children Receiving High-dose Methotrexate. Pediatric Hematology and Oncology 32:8, pages 576-584.
Read now
Read now
Articles from other publishers (54)
Mikhaila L. Rice, Erin F. Barreto, Andrew D. Rule, Catherine E. Martin, Huong L. Truong, Kristin C. Mara, Kianoush B. Kashani, Carrie A. Thompson, Thomas E. Witzig & Jason N. Barreto. (2023) Development and validation of a model to predict acute kidney injury following high‐dose methotrexate in patients with lymphoma. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.
Crossref
Crossref
Arnon Haran, Noa Gross Even-Zohar, Michal Haran, Eyal Lebel, Shlomzion Aumann, Adir Shaulov, Moshe Gatt & Boaz Nachmias. (2023) Impact of Folinic Acid Dosing on Efficacy and Toxicity of High-Dose Methotrexate in Central Nervous System Lymphoma. Clinical Lymphoma Myeloma and Leukemia.
Crossref
Crossref
Yu Cheng, Yanan Chen, Mingming Zhao, Minglu Wang, Maobai Liu & Limei Zhao. (2023) Metabolomic profiling reveals the mechanisms underlying the nephrotoxicity of methotrexate in children with acute lymphoblastic leukemia. Pediatric Blood & Cancer.
Crossref
Crossref
Caitlin Hanlon, Harry Goldberg, Angela Liang, Aaron Spjut & Stacy L. Cooper. (2023) Design and initial user experience of a computer-based decision-support tool to improve safety of chemotherapy delivery. Health and Technology 13:4, pages 659-663.
Crossref
Crossref
Luis Gros, Alicia Roldán, Almudena Cabero-Martínez, Nerea Domínguez-Pinilla, Adolfo de la Fuente, Eva González-Barca, María Tasso, Montserrat Torrent, Eva Gallardo, Inés del Cerro, Ariadna Giró-Perafita & Xavier Badia. (2022) Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study. Journal of Oncology Pharmacy Practice 29:4, pages 794-801.
Crossref
Crossref
Chun-An Liang, Yi-Chia Su, Shyh-Jer Lin & Tsung-Hsien Tsai. (2023) Risk factors for acute kidney injury after high-dose methotrexate therapy: a single-center study and narrative review. European Journal of Clinical Pharmacology 79:6, pages 789-800.
Crossref
Crossref
Joy C Zhang, Matthew J Stotts, Bethany Horton & David Schiff. (2023) Hepatotoxicity from high-dose methotrexate in primary central nervous system lymphoma. Neuro-Oncology Practice 10:3, pages 291-300.
Crossref
Crossref
Jason N. Barreto, Erin F. Barreto, Kristin C. Mara, Andrew D. Rule, John C. Lieske, Callen D. Giesen, Carrie A. Thompson, Nelson Leung, Thomas E. Witzig & Kianoush B. Kashani. (2023) Tissue Inhibitor Metalloproteinase-2 and Insulin-Like Growth Factor Binding Protein-7 Kinetics Following Exposure to High-Dose Methotrexate. Kidney360 4:5, pages 673-679.
Crossref
Crossref
Thais Fischer, Natalia PC Zing, Sergio C. Fortier, Jayr Schmidt, Talita B. Silveira & Carlos S. Chiattone. (2023) Application of the Central Nervous System International Prognostic Index (CNS-IPI) score in daily practice: a retrospective analysis apart from the clinical trial at two centers in Brazil. Hematology, Transfusion and Cell Therapy.
Crossref
Crossref
Olga Nigro, Cristina Meazza, Elisabetta Schiavello, Veronica Biassoni, Nadia Puma, Luca Bergamaschi, Giovanna Gattuso, Giovanna Sironi, Virginia Livellara, Gabriele Papagni & Maura Massimino. (2023) Acute Kidney Injury with SARS-CoV-2 Infection in Pediatric Patients Receiving High-Dose Methotrexate Chemotherapy: A Report of Three Cases. Children 10:2, pages 331.
Crossref
Crossref
Manuel Ibarra, Ryan Combs, Zachary L. Taylor, Laura B. Ramsey, Torben Mikkelsen, Randal K. Buddington, Jesper Heldrup, Jason N. Barreto, Martin Guscott, Jennifer Lowe, Charles Hurmiz, Suresh Marada, Scott C. Howard & Paula Schaiquevich. (2022) Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing. British Journal of Clinical Pharmacology 89:2, pages 660-671.
Crossref
Crossref
Sheron Latcha, Mohit Gupta, I-Hsin Lin & Edgar A. Jaimes. (2023) High Dose Methotrexate-Induced Acute Kidney Injury: Incidence, Risk Factors, and Recovery. Kidney International Reports 8:2, pages 360-364.
Crossref
Crossref
Reham G. Elfarargy, Mahmoud A. Saleh, Mohamed Mahrous Abodouh, Mahmoud A. Hamza & Nageh K. Allam. (2022) Graphitic Carbon Nitride Nanoheterostructures as Novel Platforms for the Electrochemical Sensing of the Chemotherapeutic and Immunomodulator Agent MTX. Biosensors 13:1, pages 51.
Crossref
Crossref
Janusz Hałka, Sebastian Spaleniak, Grzegorz Kade, Stefan Antosiewicz & Dawid Sigorski. (2022) The Nephrotoxicity of Drugs Used in Causal Oncological Therapies. Current Oncology 29:12, pages 9681-9694.
Crossref
Crossref
Darragh F. O'Donoghue, Huong L. Truong, Heidi D. Finnes, Jennifer S. McDonald, Heather P. May, Stephen M. Ansell, N. Nora Bennani, Thomas M. Habermann, David J. Inwards, Patrick B. Johnston, Arushi Khurana, Yi Lin, Ivana N. Micallef, Grzegorz S. Nowakowski, Jonas Paludo, Luis F. Porrata, Gita Thanarajasingam, Carrie A. Thompson, Jose C. Villasboas, Yucai Wang, Thomas E. Witzig & Nelson Leung. (2022) High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course. JCO Oncology Practice 18:12, pages e1908-e1917.
Crossref
Crossref
Kai Sun, Hongwei Tao, Tianling Ding, Ziran Li, Xiaoyan Qiu, Mingkang Zhong & Zhuo Wu. (2022) Risk factors for high‐dose methotrexate associated toxicities in patients with primary central nervous system lymphoma. Journal of Clinical Pharmacy and Therapeutics 47:12, pages 2196-2204.
Crossref
Crossref
Sheron Latcha & Chintan V. Shah. (2022) Rescue Therapies for AKI in Onconephrology: Rasburicase and Glucarpidase. Seminars in Nephrology 42:6, pages 151342.
Crossref
Crossref
Shota Kadomura, Shungo Imai, Kenji Momo, Yuki Sato, Hitoshi Kashiwagi, Tatsuya Itoh, Mitsuru Sugawara & Yoh Takekuma. (2021) Effects of piperacillin/tazobactam or cefepime on folinate dose in patients receiving high-dose methotrexate: A retrospective cohort study using Japanese administrative claims data. Journal of Oncology Pharmacy Practice 28:7, pages 1534-1542.
Crossref
Crossref
Shruti Gupta, Prakash Gudsoorkar & Kenar D. Jhaveri. (2022) Acute Kidney Injury in Critically Ill Patients with Cancer. Clinical Journal of the American Society of Nephrology 17:9, pages 1385-1398.
Crossref
Crossref
Jason N. Barreto, Kianoush B. Kashani, Kristin C. Mara, Andrew D. Rule, John C. Lieske, Callen D. Giesen, Carrie A. Thompson, Nelson Leung, Thomas E. Witzig & Erin F. Barreto. (2022) A Prospective Evaluation of Novel Renal Biomarkers in Patients With Lymphoma Receiving High-Dose Methotrexate. Kidney International Reports 7:7, pages 1690-1693.
Crossref
Crossref
Marc Ghannoum, Darren M. Roberts, David S. Goldfarb, Jesper Heldrup, Kurt Anseeuw, Tais F. Galvao, Thomas D. Nolin, Robert S. Hoffman, Valery Lavergne, Paul Meyers, Sophie Gosselin, Tudor Botnaru, Karine Mardini & David M. Wood. (2022) Extracorporeal Treatment for Methotrexate Poisoning. Clinical Journal of the American Society of Nephrology 17:4, pages 602-622.
Crossref
Crossref
Thuan Thi Minh Nguyen & Minh Hue Nguyen. (2022) Validation of a simple HPLC method to quantify methotrexate concentrations in human plasma. MedPharmRes 6:1, pages 27-32.
Crossref
Crossref
Shruti Gupta, Ignacio Portales-Castillo, Amir Daher & Abhijat Kitchlu. (2021) Conventional Chemotherapy Nephrotoxicity. Advances in Chronic Kidney Disease 28:5, pages 402-414.e1.
Crossref
Crossref
Jason N. Barreto, Kristen T. Peterson, Erin F. Barreto, Kristin C. Mara, Ross A. Dierkhising, Nelson Leung, Thomas E. Witzig & Carrie A. Thompson. (2021) Early, empiric high-dose leucovorin rescue in lymphoma patients treated with sequential doses of high-dose methotrexate. Supportive Care in Cancer 29:9, pages 5293-5301.
Crossref
Crossref
Alejandra Rosales, Alvaro Madrid, Marina Muñoz, Jose Luis Dapena & Gema Ariceta. (2021) Charcoal Hemoperfusion for Methotrexate Toxicity: A Safe and Effective Life-Rescue Alternative When Glucarpidase Is Not Available. Frontiers in Pediatrics 9.
Crossref
Crossref
Mark C. Zobeck, M. Brooke Bernhardt, Kala Y. Kamdar, Karen R. Rabin, Philip J. Lupo & Michael E. Scheurer. (2021)
Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the
ABCC4
gene
. Pediatric Blood & Cancer 68:8.
Crossref
Crossref
Shinichiro Kawaguchi, Shin-ichiro Fujiwara, Rui Murahashi, Hirotomo Nakashima, Sae Matsuoka, Takashi Ikeda, Yumiko Toda, Shoko Ito, Tetsuaki Ban, Takashi Nagayama, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine & Yoshinobu Kanda. (2021) Risk factors for high-dose methotrexate-induced nephrotoxicity. International Journal of Hematology 114:1, pages 79-84.
Crossref
Crossref
Fanny GallaisLucie ObericStanislas FaguerSuzanne TavitianThierry Lafont, Sabrina Marsili, Aurélie Brice, Etienne Chatelut & Florent Puisset. (2021) Body Surface Area Dosing of High-Dose Methotrexate Should Be Reconsidered, Particularly in Overweight, Adult Patients. Therapeutic Drug Monitoring 43:3, pages 408-415.
Crossref
Crossref
Hyehyun Jeong, Hyungwoo ChoHyeyeong KimHeejung ChaeJung-Bok LeeKyoungmin Lee, Shin KimSang-wook LeeJin-Sook Ryu, Kyung Won Kim, Eun Jin Chae, Jooryung Huh, Chan-Sik Park, Dok Hyun YoonCheolwon Suh. (2021) Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent–based analysis. Blood Advances 5:8, pages 2142-2152.
Crossref
Crossref
Shanshan Wei, Wanjun Ma, Bikui Zhang & Wenqun Li. (2021) NLRP3 Inflammasome: A Promising Therapeutic Target for Drug-Induced Toxicity. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Stephanie F Matta, Leslie A Gieselman & Robert S Mancini. (2020) A single-center qualitative study evaluating the safety and efficacy of a pharmacist-driven protocol for high-dose methotrexate management. Journal of Oncology Pharmacy Practice 27:3, pages 588-595.
Crossref
Crossref
Jéssica Berté Valer, Marina Curra, Amanda de Farias Gabriel, Tuany Rafaeli Schmidt, Maria Beatriz Cardoso Ferreira, Rafael Roesler, Junior Mario Correa Evangelista, Marco Antonio Trevizani Martins, Lauro Gregianin & Manoela Domingues Martins. (2020) Oral mucositis in childhood cancer patients receiving high‐dose methotrexate: Prevalence, relationship with other toxicities and methotrexate elimination. International Journal of Paediatric Dentistry 31:2, pages 238-246.
Crossref
Crossref
Winfried H. Alsdorf, Panagiotis Karagiannis, Claudia Langebrake, Carsten Bokemeyer & Christian Frenzel. (2021) Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment. The Oncologist 26:2, pages e327-e332.
Crossref
Crossref
Masaki MitobeKeisuke KawamotoTakaharu SuzukiTatsuya SuwabeYasuhiko ShibasakiMasayoshi MasukoKanako Inoue, Hiroaki Miyoshi, Koichi Ohshima, Hirohito SoneJun Takizawa. (2021) DA-EPOCH-R therapy for high-grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> rearrangements in a patient with renal dysfunction. Journal of Clinical and Experimental Hematopathology 61:1, pages 42-47.
Crossref
Crossref
Irina Amitai, Uri Rozovski, Reem El‐Saleh, Shai Shimony, Daniel Shepshelovich, Benaya Rozen‐Zvi, Pia Raanani, Anat Gafter‐Gvili & Ronit Gurion. (2020) Risk factors for high‐dose methotrexate associated acute kidney injury in patients with hematological malignancies. Hematological Oncology 38:4, pages 584-588.
Crossref
Crossref
Jolanta Malyszko, Petra Tesarova, Giovambattista Capasso & Anna Capasso. (2020) The link between kidney disease and cancer: complications and treatment. The Lancet 396:10246, pages 277-287.
Crossref
Crossref
Chenrong Huang, Fan Xia, Ling Xue, Linsheng Liu, Yicong Bian, Zhengming Jin & Liyan Miao. (2019) Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3. Cancer Chemotherapy and Pharmacology 85:2, pages 433-441.
Crossref
Crossref
Yuxia Shan, Hui Gao, Zhong Li, Jinghua Li, Yang Liu, Lujuan Li & Qi Zhang. (2020) Retrospective evaluation and prediction of clearance and toxicity of high dose methotrexate in childhood acute lymphoblastic leukemia patients. Brazilian Journal of Pharmaceutical Sciences 56.
Crossref
Crossref
Saleem H. Aladaileh, Omnia E. Hussein, Mohammad H. Abukhalil, Sultan A. M. Saghir, May Bin-Jumah, Manal A. Alfwuaires, Mousa O. Germoush, Amer A. Almaiman & Ayman M. Mahmoud. (2019) Formononetin Upregulates Nrf2/HO-1 Signaling and Prevents Oxidative Stress, Inflammation, and Kidney Injury in Methotrexate-Induced Rats. Antioxidants 8:10, pages 430.
Crossref
Crossref
Sanaa M. Abd El-Twab, Omnia E. Hussein, Walaa G. Hozayen, May Bin-Jumah & Ayman M. Mahmoud. (2019) Chicoric acid prevents methotrexate-induced kidney injury by suppressing NF-κB/NLRP3 inflammasome activation and up-regulating Nrf2/ARE/HO-1 signaling. Inflammation Research 68:6, pages 511-523.
Crossref
Crossref
Mineaki Kitamura, Satoko Kitamura, Machiko Fujioka, Rena Kamijo, Shinya Sato, Yasushi Sawayama, Tadashi Uramatsu, Yoko Obata, Yasushi Mochizuki, Masaharu Nishikido, Hideki Sakai, Yasushi Miyazaki, Hiroshi Mukae & Tomoya Nishino. (2018) Methotrexate-induced acute kidney injury in patients with hematological malignancies: three case reports with literature review. Renal Replacement Therapy 4:1.
Crossref
Crossref
Hugo Garcia, Véronique Leblond, François Goldwasser, Didier Bouscary, Emmanuel Raffoux, Nicolas Boissel, Sophie Broutin & Dominique Joly. (2018) Toxicité rénale du méthotrexate à haute dose. Néphrologie & Thérapeutique 14, pages S103-S113.
Crossref
Crossref
Florence Ranchon, Nicolas Vantard, Emilie Henin, Emmanuel Bachy, Clémentine Sarkozy, Lionel Karlin, Fadhela Bouafia-Sauvy, Aurore Gouraud, Verane Schwiertz, Estelle Bourbon, Amandine Baudouin, Anne Gaelle Caffin, Thierry Vial, Gilles Salles & Catherine Rioufol. (2018) Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?. Hematological Oncology 36:2, pages 399-406.
Crossref
Crossref
Prateek Tiwari, Prasanth Ganesan, Venkatraman Radhakrishnan, Rajamanickam Arivazhagan, Trivadi S. Ganesan, Manikandan Dhanushkodi, Sidharth Totadri & Tenali Gnana Sagar. (2018) Prospective evaluation of the toxicity profile, and predictors of toxicity of high dose methotrexate in patients of acute lymphoblastic leukemia/lymphoma. Pediatric Hematology Oncology Journal 3:1, pages 1-5.
Crossref
Crossref
Laura B. Ramsey, Frank M. Balis, Maureen M. O'Brien, Kjeld Schmiegelow, Jennifer L. Pauley, Archie Bleyer, Brigitte C. Widemann, David Askenazi, Sharon Bergeron, Anushree Shirali, Stefan Schwartz, Alexander A. Vinks & Jesper Heldrup. (2018) Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance. The Oncologist 23:1, pages 52-61.
Crossref
Crossref
Jennifer S Steward, Heather M Bullard, Timothy J O’Rourke, Alan D Campbell, Brett T Brinker, Kathleen J Yost, Amy C Vanderwoude, William L Scott & Polly E Kintzel. (2016) Effect of single agent high-dose methotrexate-related acute kidney injury on length of hospitalization and relative dose intensity in adult patients with central nervous system lymphoma. Journal of Oncology Pharmacy Practice 23:7, pages 496-501.
Crossref
Crossref
Collin K. Chin & Chan Yoon Cheah. (2017) How I treat patients with aggressive lymphoma at high risk of CNS relapse. Blood 130:7, pages 867-874.
Crossref
Crossref
Dominique Levêque, Guillaume Becker, Elise Toussaint, Luc-Matthieu Fornecker & Catherine Paillard. (2017) Clinical pharmacokinetics of methotrexate in oncology. International Journal of Pharmacokinetics 2:2, pages 137-147.
Crossref
Crossref
Thanh P. Ho, Paolo Strati & Tony Y. Chon. (2017) 65-Year-Old Man With Weight Loss and Progressive Acral Necrosis. Mayo Clinic Proceedings 92:4, pages 605-608.
Crossref
Crossref
Yasemin Yuksel, Ramazan Yuksel, Murat Yagmurca, Hacer Haltas, Husamettin Erdamar, Muhsin Toktas & Osman Ozcan. (2016) Effects of quercetin on methotrexate-induced nephrotoxicity in rats. Human & Experimental Toxicology 36:1, pages 51-61.
Crossref
Crossref
Scott C. Howard, John McCormick, Ching-Hon Pui, Randall K. Buddington & R. Donald Harvey. (2016) Preventing and Managing Toxicities of High-Dose Methotrexate. The Oncologist 21:12, pages 1471-1482.
Crossref
Crossref
Masahito Tsurusawa, Masahiko Gosho, Tetsuya Mori, Tetsuo Mitsui, Shosuke Sunami, Ryoji Kobayashi, Reiji Fukano, Fumiko Tanaka, Naoto Fujita, Hiroko Inada, Katsuyoshi Koh, Tetsuya Takimoto, Akiko Saito, Junichiro Fujimoto, Atsuko Nakazawa & Keizo Horibe. (2015) Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood nonHodgkin lymphoma. Pediatric Blood & Cancer 62:2, pages 279-284.
Crossref
Crossref
Yu-Chin Lin, Chung-Ping Yu, Shiuan-Pey Lin, Pei-Wen Hsu, Pei-Dawn Lee Chao, Yu-Chi Hou & Shin-Hun Juang. (2014) Potential modulation on BCRP and MRP 4 by onion: in vivo and ex-vivo studies. Journal of Functional Foods 8, pages 243-251.
Crossref
Crossref
I-Hsin Lin, Sheron Latcha & Mohit Gupta. (2021) Methotrexate-Induced AKI: Incidence, Risk Factors and Recovery. SSRN Electronic Journal.
Crossref
Crossref